Wael Fayad

Wael Fayad has over 25 years of experience in the life sciences industry. He served as head of business development at Forest Laboratories Inc. and was a member of the leadership team that built Forest into a leading U.S. pharma company which was acquired for $28 billion. Prior to Forest, Mr. Fayad served at Novartis and Schering-Plough in various commercial and strategy roles. After leaving Forest, he worked with a number of smaller biotech and healthcare-oriented companies, including Enumeral Biomedical, where he served as Chairman and CEO, and ACCOY pharmaceuticals, where he co-founded the company and serves on its strategic advisory board.

Mr. Fayad holds a bachelor's degree in Biology from the American University of Beirut and a Masters of Business Administration degree from Concordia University in Montreal, Canada.